The International Northeast Biotechnology Corridor was created in 1998 through a resolution passed at the New England Governors’ and Eastern Canadian Premiers’ Conference [Resolution 23-6 Resolution of an International Northeast Biotechnnology Corridor (PDF-408K)] to support biotechnology development in the region.
The International Northeast Biotechnology Corridor (INBC) is a non-profit entity that was incorporated in the State of Maine [1999 – Articles of Incorporation (PDF – 948K)] in 1999 and has a principal place of business in Fairfield, Maine . The purpose of the corporation is to promote biotechnological development for the benefit of the members of the international Northeast Biotechnology Corridor, to create a favorable business atmosphere for existing biotechnotogical enterprises and industries, and to carry out these goals within the scope of its legal corporate powers. The Corporation will work in coordination with Corridor members, and other entities to achieve these goals.
The Corridor is expected to be a collection of eleven Provinces and States. It was defined as the region reaching from Rhode Island in the United States to Newfoundland in Canada, bounded by the Province of Quebec as the western boundary of the Eastern Provinces and with Connecticut being the western boundary of the New England region. In 1999, the resolution for the corridor was reaffirmed by the New England Governors and Eastern Canadian Premiers.